Mouse matriptase-2: identification, characterization and comparative mRNA expression analysis with mouse hepsin in adult and embryonic tissues
Open Access
- 1 August 2003
- journal article
- Published by Portland Press Ltd. in Biochemical Journal
- Vol. 373 (3) , 689-702
- https://doi.org/10.1042/bj20030390
Abstract
We report the identification and characterization of mouse matriptase-2 (m-matriptase-2), an 811-amino-acid protein composed of an N-terminal cytoplasmic domain, a membrane-spanning domain, two CUB (complement protein subcomponents C1r/C1s, urchin embryonic growth factor and bone morphogenetic protein 1) domains, three LDLR (low-density-lipoprotein receptor class A) domains and a C-terminal serine-protease domain. All m-matriptase-2 protein domain boundaries corresponded with intron/exon junctions of the encoding gene, which spans approx. 29 kb and comprises 18 exons. Matriptase-2 is highly conserved in human, mouse and rat, with the rat matriptase-2 gene (r-maltriptase-2) predicted to encode transmembrane and soluble isoforms. Western-blot analysis indicated that m-matriptase-2 migrates close to its theoretical molecular mass of 91 kDa, and immunofluorescence analysis was consistent with the proposed surface membrane localization of this protein. Reverse-transcription PCR and in-situ-hybridization analysis indicated that m-matriptase-2 expression overlaps with the distribution of mouse hepsin (m-hepsin, a cell-surface serine protease identified in hepatoma cells) in adult tissues and during embryonic development. In adult tissues both are expressed at highest levels in liver, kidney and uterus. During embryogenesis m-matriptase-2 expression peaked between days 12.5 and 15.5. m-hepsin expression was biphasic, with peaks at day 7.5 to 8.5 and again between days 12.5 and 15.5. In situ hybridization of embryonic tissues indicated abundant expression of both m-matriptase-2 and m-hepsin in the developing liver and at lower levels in developing pharyngo–tympanic tubes. While m-hepsin was detected in the residual embryonic yolk sac and with lower intensity in lung, heart, gastrointestinal tract, developing kidney tubules and epithelium of the oral cavity, m-matriptase-2 was absent in these tissues, but strongly expressed within the nasal cavity by olfactory epithelial cells. Mechanistic insight into the potential role of this new transmembrane serine protease is provided by its novel expression profile in embryonic and adult mouse.Keywords
This publication has 58 references indexed in Scilit:
- Matriptase-2, a Membrane-bound Mosaic Serine Proteinase Predominantly Expressed in Human Liver and Showing Degrading Activity against Extracellular Matrix ProteinsJournal of Biological Chemistry, 2002
- Decrease and Gain of Gene Expression Are Equally Discriminatory Markers for Prostate CarcinomaThe American Journal of Pathology, 2002
- Matriptase/MT-SP1 is required for postnatal survival, epidermal barrier function, hair follicle development, and thymic homeostasisOncogene, 2002
- Processing of Pro-atrial Natriuretic Peptide by Corin in Cardiac MyocytesJournal of Biological Chemistry, 2002
- Expression of the serine protease matriptase and its inhibitor HAI-1 in epithelial ovarian cancer: correlation with clinical outcome and tumor clinicopathological parameters.2002
- Spinesin/TMPRSS5, a Novel Transmembrane Serine Protease, Cloned from Human Spinal CordJournal of Biological Chemistry, 2002
- The PROSITE database, its status in 2002Nucleic Acids Research, 2002
- Catalytic Domain Structures of MT-SP1/Matriptase, a Matrix-degrading Transmembrane Serine ProteinaseJournal of Biological Chemistry, 2002
- N-terminal Processing Is Essential for Release of Epithin, a Mouse Type II Membrane Serine ProteasePublished by Elsevier ,2001
- Reverse biochemistry: Use of macromolecular protease inhibitors to dissect complex biological processes and identify a membrane-type serine protease in epithelial cancer and normal tissueProceedings of the National Academy of Sciences, 1999